Lulutox Detox Tea officially launches across Ireland, the USA, UK, Australia and Canada. Formulated with natural herbs like ...

D-Bal – Mimicking the effects of Dianabol, D-Bal boosts nitrogen retention and protein synthesis for rapid muscle growth.

Hapbee Technologies Inc. (TSXV: HAPB | OTCQB: HAPBF), (“Hapbee” or the “Company”), the digital wellness technology company pioneering the science of bio-streaming, announced today its operational and ...

“Exosomes offer exciting possibilities as cell-free tools in regenerative medicine,” said Dr. Ruby Tsai, CEO of Applied StemCell. “Our hiEX™ iPSC Exosomes give researchers a dependable and ...

CROSSJECT announces a successful capital increase of €5.7 million following full exercise of the extension clause En cliquant sur ce lien, vous acceptez l'utilisation de cookies sur ce site internet.

The 18-month study, initiated in 2022 and completed in late 2023, leveraged Inventprise’s proprietary linker protein conjugation technology platform. This advanced technology is designed to enhance ...

GN Store Nord A/S hereby announces that on June 23, 2025, pursuant to Section 38 (1) and Section 39 (1) of the Danish Capital Markets Act, it received a notification from BlackRock, Inc. stating that ...

La maladie d’Alzheimer touche près d’un million de personnes en France, avec environ 225.000 nouveaux cas diagnostiqués ...

Priothera Secures €1.7 million i-Nov Funding by Bpifrance for Rare Blood Cancer Clinical Program Funding to support MOCART, a clinical programme evaluating mocravimod added to standard CAR-T cell ...

Zarminali Pediatrics, the first outpatient pediatric destination purpose-built to provide elevated, seamlessly coordinated primary and specialty care nationwide, announced that Green Tree Pediatrics ...

The designation reinforces the potential of QRX003 as a therapeutic candidate for a profoundly underserved pediatric population. It follows earlier regulatory recognition by the European Medicines ...

Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that the Company completed the second closing ...